https://maglepharmacept.com/positive-results-from-post-market-clinical-follow-up-of-magle-groups-innovative-medical-device-smartpan-presented-at-scientific-congress/ 2023-11-16T14:26:39+00:00 monthly 0.2 https://maglepharmacept.com/magle-group-initiates-collaboration-with-leading-german-university-hospital-to-explore-synergies-between-embocept-s-dsm-50-%c2%b5m-and-immunotherapies-2/ 2023-11-21T09:00:21+00:00 monthly 0.2 https://maglepharmacept.com/magle-group-enters-collaboration-with-sirtex-medical-to-support-the-international-commercialization-of-embocept-s-dsm-50-%c2%b5m-2/ 2023-11-21T09:01:58+00:00 monthly 0.2 https://maglepharmacept.com/degradable-starch-microspheres-transarterial-chemoembolization-with-or-without-lipiodol-for-liver-metastases-from-pancreatic-cancer-a-prospective-randomized-trial-2/ 2023-11-24T09:13:26+00:00 monthly 0.2 https://maglepharmacept.com/43rd-annual-meeting-of-the-german-pancreas-club/ 2024-03-11T14:24:12+00:00 monthly 0.2 https://maglepharmacept.com/magle-group-announces-appointment-of-distributor-for-smartpan-in-singapore/ 2024-06-04T12:39:46+00:00 monthly 0.2 https://maglepharmacept.com/magle-pharmacept-announces-participation-in-the-et2024-congress-in-vienna/ 2024-06-04T13:11:00+00:00 monthly 0.2 https://maglepharmacept.com/breaking-news-magle-chemoswed-as-a-part-of-magle-group-supercharges-capabilities-with-new-automated-syringe-filling-and-closing-line/ 2024-06-19T08:57:52+00:00 monthly 0.2 https://maglepharmacept.com/magle-pharmacept-expands-distribution-agreement-to-include-strategic-european-territories/ 2024-07-01T08:30:05+00:00 monthly 0.2 https://maglepharmacept.com/cirse-2024/ 2025-10-07T08:09:34+00:00 monthly 0.2 https://maglepharmacept.com/magle-group-approves-multi-centre-clinical-trial-in-genicular-artery-embolisation-for-osteoarthritis-pain-relief/ 2024-12-21T14:26:03+00:00 monthly 0.2 https://maglepharmacept.com/magle-group-announces-publication-of-prospective-hepastar-trial-results-highlighting-promising-outcomes-for-dsm-tace-in-hepatocellular-carcinoma/ 2025-01-07T11:14:22+00:00 monthly 0.2 https://maglepharmacept.com/magle-pharmacept-team-will-be-participating-at-44th-annual-meeting-of-the-german-pancreatic-club-in-heidelberg/ 2025-02-03T13:36:27+00:00 monthly 0.2 https://maglepharmacept.com/smartpan-pmcf-study-results-are-published/ 2025-04-02T14:26:39+00:00 monthly 0.2 https://maglepharmacept.com/magle-pharmacept-partners-with-pancreatic-cancer-europe-pce-to-advance-innovation-in-pancreatic-cancer-care/ 2025-04-25T09:09:08+00:00 monthly 0.2 https://maglepharmacept.com/truly-an-inspiring-experience-at-european-pancreatic-club-epc-2025-in-dusseldorf-germany/ 2025-08-20T14:37:57+00:00 monthly 0.2 https://maglepharmacept.com/dr-federico-collettini-awarded-prestigious-medical-research-award-by-magle-pharmacept/ 2025-09-15T08:41:42+00:00 monthly 0.2 https://maglepharmacept.com/magle-group-secures-registration-of-smartpan-in-singapore-enabling-launch-in-pancreatic-surgery/ 2025-10-07T08:15:14+00:00 monthly 0.2 https://maglepharmacept.com/magle-group-announces-positive-clinical-evidence-review-of-embocept-s-for-genicular-artery-embolisation-gae-regulatory-filing-in-europe-now-in-preparation/ 2025-10-20T09:27:19+00:00 monthly 0.2 https://maglepharmacept.com/magle-group-sponsors-inaugural-venti-conference-in-tokyo-japan-supporting-innovation-in-vascular-embolotherapy-and-pain-interventions/ 2025-10-24T10:01:10+00:00 monthly 0.2 https://maglepharmacept.com/magle-group-completes-european-medical-device-filing-for-the-use-of-embocepts-dsm-50%c2%b5m-in-genicular-artery-embolisation/ 2025-11-18T11:27:36+00:00 monthly 0.2 https://maglepharmacept.com/magle-group-enters-strategic-distribution-agreement-with-rifa-pharma-for-smartpan-and-smartgel-in-india/ 2025-12-02T13:10:17+00:00 monthly 0.2 https://maglepharmacept.com/magle-group-and-sirtex-medical-extend-exclusive-partnership-to-accelerate-global-value-creation-in-embolisation/ 2026-01-13T12:12:55+00:00 monthly 0.2 https://maglepharmacept.com/sirtex-magle-pharmacept-partner-to-shape-the-future-of-embolization/ 2026-01-15T14:28:18+00:00 monthly 0.2